Matches in Wikidata for { <http://www.wikidata.org/entity/Q93066715> ?p ?o ?g. }
Showing items 1 to 55 of
55
with 100 items per page.
- Q93066715 description "artículu científicu espublizáu en payares de 2018" @default.
- Q93066715 description "scientific article published on 14 November 2018" @default.
- Q93066715 description "wetenschappelijk artikel" @default.
- Q93066715 description "наукова стаття, опублікована в листопаді 2018" @default.
- Q93066715 name "Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy" @default.
- Q93066715 name "Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy" @default.
- Q93066715 type Item @default.
- Q93066715 label "Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy" @default.
- Q93066715 label "Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy" @default.
- Q93066715 prefLabel "Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy" @default.
- Q93066715 prefLabel "Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy" @default.
- Q93066715 P1433 Q93066715-35E088CB-95C1-4C83-8F61-06E94CC7B1D9 @default.
- Q93066715 P1476 Q93066715-721C6C1C-C3CD-4547-8EF6-BF9C03A03BAE @default.
- Q93066715 P2093 Q93066715-13763E8E-3D70-46C7-9657-9E4024439E4B @default.
- Q93066715 P2093 Q93066715-A3B9F223-5891-41F3-9E90-91BAA4A06D6D @default.
- Q93066715 P2093 Q93066715-A9C55B2A-B973-45E9-9348-E21E73E7A475 @default.
- Q93066715 P2093 Q93066715-ED592DD9-2E15-4D18-8EA0-7C853FDF0A36 @default.
- Q93066715 P2093 Q93066715-F0AFD5AC-1194-4ACE-B185-5B26994A010C @default.
- Q93066715 P2860 Q93066715-D4585D17-AB71-449C-A694-9D168C46D10B @default.
- Q93066715 P304 Q93066715-1DC1807C-8C68-4B33-9A1E-74EFFCCD694F @default.
- Q93066715 P31 Q93066715-757534F1-02EF-48CD-AB4F-215B0D50F5BF @default.
- Q93066715 P356 Q93066715-A89E7D43-5FB5-47BC-9335-10871AB95776 @default.
- Q93066715 P433 Q93066715-4CB9C4BA-E142-494A-B855-A05A347CC516 @default.
- Q93066715 P478 Q93066715-FBE8BD1B-EE3A-47E8-81A7-CD29E4157D6D @default.
- Q93066715 P50 Q93066715-14B82432-9953-4360-AEA8-F123E2EF3C9B @default.
- Q93066715 P50 Q93066715-6A0D0592-4C87-475A-8E46-16A8C02C5538 @default.
- Q93066715 P50 Q93066715-C11CC812-93AF-45AB-A353-882C0DAE0543 @default.
- Q93066715 P577 Q93066715-A600300F-A9E5-4D0D-9789-BFB77D24DBB8 @default.
- Q93066715 P698 Q93066715-13E2EE94-91F1-49E5-81BB-80CFA711EC11 @default.
- Q93066715 P921 Q93066715-2BB21ECF-7063-4B40-8C3D-A30E388F08F2 @default.
- Q93066715 P921 Q93066715-96C14804-37EF-46BA-8DD9-43F50BDBEB39 @default.
- Q93066715 P921 Q93066715-EF5FE784-1EF9-4872-8532-CC2CEC335C19 @default.
- Q93066715 P356 PTR.6230 @default.
- Q93066715 P698 30427093 @default.
- Q93066715 P1433 Q7189844 @default.
- Q93066715 P1476 "Randomized, double-blind, placebo-controlled phase II trial of nanocurcumin in prostate cancer patients undergoing radiotherapy" @default.
- Q93066715 P2093 "Afshin Saadipoor" @default.
- Q93066715 P2093 "Hamid Abdollahi" @default.
- Q93066715 P2093 "Maryam Moghadam" @default.
- Q93066715 P2093 "Mohsen Bakhshandeh" @default.
- Q93066715 P2093 "Nasser Simforoosh" @default.
- Q93066715 P2860 Q30841584 @default.
- Q93066715 P304 "370-378" @default.
- Q93066715 P31 Q13442814 @default.
- Q93066715 P356 "10.1002/PTR.6230" @default.
- Q93066715 P433 "2" @default.
- Q93066715 P478 "33" @default.
- Q93066715 P50 Q57624234 @default.
- Q93066715 P50 Q89403444 @default.
- Q93066715 P50 Q93066712 @default.
- Q93066715 P577 "2018-11-14T00:00:00Z" @default.
- Q93066715 P698 "30427093" @default.
- Q93066715 P921 Q181257 @default.
- Q93066715 P921 Q269829 @default.
- Q93066715 P921 Q42824440 @default.